Follow-up of infants with congenital hypothyroidism and low total thyroxine/thyroid stimulating hormone on newborn screen
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Newborn screening (NBS) methods to detect congenital hypothyroidism (CH) vary regarding whether total thyroxine (T4), thyroid stimulating hormone (TSH), or both are measured. Neonates with low T4 and normal or low TSH (lowT4/TSH) may only be detected by T4-inclusive methods or age-dependent repeat screens. Premature neonates and those with pituitary-hypothalamic disorders frequently manifest lowT4/TSH. Methods: This is a retrospective case-study of newborns who were screen-positive for lowT4/TSH in Alabama in 2009–2016 using a combined T4 and TSH method and 2 routine NBS. The clinical, laboratory, and final diagnosis after 3 years were determined. Results: Over 8 years, 225 infants were referred to our institution for evaluation and treatment of CH. Twelve infants were screen-positive for lowT4/TSH by first or second NBS. Four of the 12 infants had permanent CH (30%): 2 with primary and 2 with central etiologies. One infant with moderately severe central CH was only detected by the routine second NBS. Six of 7 premature infants had elevated TSH on serum confirmation labs consistent with a delay in hypothalamic-pituitary maturation, yet 2 of these patients were later established to have permanent primary CH. While most cases of lowT4/TSH resolved by 3 years of age, several neonates had extended periods of moderate to severe hypothyroxinemia prior to detection and treatment. Conclusion: One third of the infants with lowT4/TSH on NBS in this study had permanent CH. These results emphasize the importance of T4-based assay methods, subsequent (repeat) screens and long-term follow-up in the management of neonates with lowT4/TSH on newborn screen.
Abstract
Purpose: Newborn screening (NBS) methods to detect congenital hypothyroidism (CH) vary regarding whether total thyroxine (T4), thyroid stimulating hormone (TSH), or both are measured. Neonates with low T4 and normal or low TSH (lowT4/TSH) may only be detected by T4-inclusive methods or age-dependent repeat screens. Premature neonates and those with pituitary-hypothalamic disorders frequently manifest lowT4/TSH. Methods: This is a retrospective case-study of newborns who were screen-positive for lowT4/TSH in Alabama in 2009–2016 using a combined T4 and TSH method and 2 routine NBS. The clinical, laboratory, and final diagnosis after 3 years were determined. Results: Over 8 years, 225 infants were referred to our institution for evaluation and treatment of CH. Twelve infants were screen-positive for lowT4/TSH by first or second NBS. Four of the 12 infants had permanent CH (30%): 2 with primary and 2 with central etiologies. One infant with moderately severe central CH was only detected by the routine second NBS. Six of 7 premature infants had elevated TSH on serum confirmation labs consistent with a delay in hypothalamic-pituitary maturation, yet 2 of these patients were later established to have permanent primary CH. While most cases of lowT4/TSH resolved by 3 years of age, several neonates had extended periods of moderate to severe hypothyroxinemia prior to detection and treatment. Conclusion: One third of the infants with lowT4/TSH on NBS in this study had permanent CH. These results emphasize the importance of T4-based assay methods, subsequent (repeat) screens and long-term follow-up in the management of neonates with lowT4/TSH on newborn screen.
참고문헌 (26)
- Léger J, "European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism", J Clin Endocrinol Metab, 99, pp.363~384 (2014)
- Shapira SK, "Single newborn screen or routine second screening for primary congenital hypothyroidism", Mol Genet Metab, 116, pp.125~132 (2015)
- Ford GA, "Transient versus permanent congenital hypothyroidism after the age of 3 years in infants detected on the first versus second newborn screening test in Oregon, USA", Horm Res Paediatr, 86, pp.169~177 (2016)
- Jones DE, "Identification of primary congenital hypothyroidism based on two newborn screens - Utah, 2010-2016", MMWR Morb Mortal Wkly Rep, 67, pp.782~785 (2018)
- Kilberg MJ, "Newborn screening in the US may miss mild persistent hypothyroidism", J Pediatr, 192, pp.204~208 (2018)
- Woo HC, "Congenital hypothyroidism with a delayed thyroidstimulating hormone elevation in very premature infants:incidence and growth and developmental outcomes", J Pediatr, 158, pp.538~542 (2011)
- Zung A, "Characteristics of Delayed thyroid stimulating hormone elevation in neonatal intensive care unit newborns", J Pediatr, 178, pp.135~140.e1 (2016)
- Vigone MC, "Evolution of thyroid function in preterm infants detected by screening for congenital hypothyroidism", J Pediatr, 164, pp.1296~1302 (2014)
- McGrath N, "Optimal timing of repeat newborn screening for congenital hypothyroidism in preterm infants to detect delayed thyroid-stimulating hormone elevation", J Pediatr, 205, pp.77~82 (2019)
- Nebesio TD, "Newborn screening results in children with central hypothyroidism", J Pediatr, 156, pp.990~993 (2010)
- Zwaveling-Soonawala N, "The severity of congenital hypothyroidism of central origin should not be underestimated", J Clin Endocrinol Metab, 100, pp.E297~E300 (2015)
- Connelly KJ, "Detection of neonates with mild congenital hypothyroidism (primary) or isolated hyperthyrotropinemia: an increasingly common management dilemma", Expert Rev Endocrinol Metab, 9, pp.263~271 (2014)
- LaFranchi SH, "Approach to the diagnosis and treatment of neonatal hypothyroidism", J Clin Endocrinol Metab, 96, pp.2959~2967 (2011)
- American Academy of Pediatrics, "Update of newborn screening and therapy for congenital hypothyroidism", Pediatrics, 117, pp.2290~2303 (2006)
- Schushan-Eisen I, "Thyroid functions in healthy infants during the first year of life", J Pediatr, 170, pp.120~125.e1 (2016)
- Wassner AJ, "Subclinical hypothyroidism in infancy: to treat or not to treat, that is the question", J Pediatr, 170, pp.17~19 (2016)
- Braslavsky D, "Pilot neonatal screening program for central congenital hypothyroidism: evidence of significant detection", Horm Res Paediatr, 88, pp.274~280 (2017)
- Ahmet A, "Hypothyroidism in neonates post-iodinated contrast media: a systematic review", Acta Paediatr, 98, pp.1568~1574 (2009)
- Barr ML, "Thyroid dysfunction in children exposed to iodinated contrast media", J Clin Endocrinol Metab, 101, pp.2366~2370 (2016)
- Cuestas E, "Transient neonatal hyperthyrotropinemia is a risk factor for developing persistent hyperthyrotropinemia in childhood with repercussion on developmental status", Eur J Endocrinol, 172, pp.483~490 (2015)
- 임한혁, "Risk factor for pituitary dysfunction in children and adolescents with Rathke’s cleft cysts", Clinical and Experimental Pediatrics, 53(7), pp.759~765 (2010), 대한소아청소년과학회
- Schoenmakers N, "Recent advances in central congenital hypothyroidism", J Endocrinol, 227, pp.R51~R71 (2015)
- Van den Berghe G, "Dopamine suppresses pituitary function in infants and children", Crit Care Med, 22, pp.1747~1753 (1994)
- Tonyushkina KN, "Low thyroid hormone levels disrupt thyrotrope development", Endocrinology, 158, pp.2774~2782 (2017)
- Huang SA, "Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas", N Engl J Med, 343, pp.185~189 (2000)
- Luongo C, "Type 3deiodinase and consumptive hypothyroidism: a common mechanism for a rare disease", Front Endocrinol (Lausanne), 4, pp.115~ (2013)